Evidence map›Paper›PMID 37291382›Full record

SynthesisClinical rheumatology2023

What are the core recommendations for rheumatoid arthritis care? Systematic review of clinical practice guidelines.

Brooke Conley, Samantha Bunzli, Jonathan Bullen, Penny O'Brien, Jennifer Persaud, Tilini Gunatillake, Mandana Nikpour, Rebecca Grainger, Cheryl Barnabe, Ivan Lin

Abstract readSystematic Review
In one paragraph

Synthesis in Clinical rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in immunology · 2025
    Article
  18. Article
  19. Rheumatoid arthritis treatment: Is exercise a game changer?Turkish journal of physical medicine and rehabilitation · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brooke ConleyDepartment of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia. bccon@student.unimelb.edu.au.ORCID http://orcid.org/0000-0002-1677-4540
Samantha BunzliDepartment of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia.
Jonathan BullenEnAble Institute, Curtin University, Perth, WA, Australia.
Penny O'BrienDepartment of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
Jennifer PersaudArthritis and Osteoporosis Western Australia, Perth, WA, Australia.
Tilini GunatillakeDepartment of Surgery, The University of Melbourne, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
Mandana NikpourDepartments of Medicine and Rheumatology Melbourne, The University of Melbourne at St. Vincent's Hospital, Melbourne, VIC, Australia.
Rebecca GraingerDepartment of Medicine, University of Otago Wellington, Wellington, New Zealand.
Cheryl BarnabeDepartments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Ivan LinWestern Australian Centre for Rural Health, The University of Western Australia, Geraldton, WA, Australia.

Funding

Arthritis Australia GA76063
6 · The paper itself

Abstract

Systematic r eview to evaluate the quality of the clinical practice guidelines (CPG) for rheumatoid arthritis (RA) management and to provide a synthesis of high-quality CPG recommendations, highlighting areas of consistency, and inconsistency. Electronic searches of five databases and four online guideline repositories were performed. RA management CPGs were eligible for inclusion if they were written in English and published between January 2015 and February 2022; focused on adults ≥ 18 years of age; met the criteria of a CPG as defined by the Institute of Medicine; and were rated as high quality on the Appraisal of Guidelines for Research and Evaluation II instrument. RA CPGs were excluded if they required additional payment to access; only addressed recommendations for the system/organization of care and did not include interventional management recommendations; and/or included other arthritic conditions. Of 27 CPGs identified, 13 CPGs met eligibility criteria and were included. Non-pharmacological care should include patient education, patient-centered care, shared decision-making, exercise, orthoses, and a multi-disciplinary approach to care. Pharmacological care should include conventional synthetic disease modifying anti-rheumatic drugs (DMARDs), with methotrexate as the first-line choice. If monotherapy conventional synthetic DMARDs fail to achieve a treatment target, this should be followed by combination therapy conventional synthetic DMARDs (leflunomide, sulfasalazine, hydroxychloroquine), biologic DMARDS and targeted synthetic DMARDS. Management should also include monitoring, pre-treatment investigations and vaccinations, and screening for tuberculosis and hepatitis. Surgical care should be recommended if non-surgical care fails. This synthesis offers clear guidance of evidence-based RA care to healthcare providers.

trial registrationThe protocol for this review was registered with Open Science Framework ( https://doi.org/10.17605/OSF.IO/UB3Y7 ).

Indexed as

Antirheumatic AgentsArthritis, RheumatoidAdultHumansHydroxychloroquineMethotrexatePractice Guidelines as TopicSulfasalazineAntirheumatic AgentsHydroxychloroquineMethotrexateSulfasalazineEvidence-based careEvidence-based medicinePractice guidelinesRheumatoid arthritisSystematic review

Identifiers

PMID37291382
PMCPMC10412487

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.